{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:27:33Z","timestamp":1794360453274,"version":"4.9.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI186969"],"award-info":[{"award-number":["U01AI186969"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI193496"],"award-info":[{"award-number":["R21AI193496"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI186969"],"award-info":[{"award-number":["U01AI186969"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006512","name":"School of Medicine, Duke University","doi-asserted-by":"publisher","award":["Whitehead scholar Award"],"award-info":[{"award-number":["Whitehead scholar Award"]}],"id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Following radiation injury, intestinal epithelial cells adapt through cellular plasticity to regenerate and repopulate the damaged epithelium by activating Yap, a key effector protein of the Hippo signaling pathway. However, the impact of pharmacologically targeting the Hippo pathway on the regeneration of the irradiated intestinal epithelium remains poorly understood. Here, we investigated this question using NCGC-023, a selective and potent small-molecule inhibitor of Yap\u2019s upstream regulators LATS1\/2. NCGC-023 treatment significantly increased active Yap protein expression in human enteroids and protected them against ionizing radiation (IR) in vitro. In mice, transient treatment with NCGC-023 before IR reduced radiation-induced DNA damage, suppressed premitotic apoptosis and aberrant mitosis in intestinal crypt cells, facilitated regenerative reprogramming of the damaged intestinal epithelium, and improved survival of mice subjected to IR doses that precipitate gastrointestinal acute radiation syndrome (GI-ARS). Mechanistically, NCGC-023 treatment before IR upregulated key signaling pathways controlled by LATS1\/2, including Yap-dependent regenerative responses involving Il-33 and Yap-independent cellular responses to heavy metals mediated by metallothioneins. Moreover, NCGC-023 treatment did not exacerbate delayed injury in multiple organs of mice that survived 4 months post-irradiation. Together, these results demonstrate that transient NCGC-023 treatment before high-dose IR promotes the regeneration of the damaged intestinal epithelium. This proof-of-concept study supports further development of LATS1\/2 inhibitors as prophylactic medical countermeasures for GI-ARS.<\/jats:p>","DOI":"10.1038\/s41536-026-00496-5","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:04:29Z","timestamp":1784567069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prophylactic inhibition of LATS1\/2 before high-dose irradiation promotes the regeneration of the damaged intestinal epithelium"],"prefix":"10.1038","volume":"11","author":[{"given":"Lucy M.","family":"Driver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances Anne","family":"Tosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget S.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Harbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayra","family":"Charania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien Y.","family":"Duveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Evsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthana","family":"Kurapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koravit","family":"Poysungnoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Eyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Lung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","unstructured":"Dainiak, N. & Albanese, J. Medical management of acute radiation syndrome. J. Radiol Prot. 42, https:\/\/doi.org\/10.1088\/1361-6498\/ac7d18 (2022).","DOI":"10.1088\/1361-6498\/ac7d18"},{"key":"496_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/HP.0b013e318266ee13","volume":"103","author":"C Booth","year":"2012","unstructured":"Booth, C., Tudor, G., Tudor, J., Katz, B. P. & MacVittie, T. J. Acute gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 103, 383\u2013399 (2012).","journal-title":"Health Phys."},{"key":"496_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41420-025-02525-6","volume":"11","author":"ML Freeman","year":"2025","unstructured":"Freeman, M. L. Gastrointestinal acute radiation syndrome: Current knowledge and perspectives. Cell Death Discov. 11, 235 (2025).","journal-title":"Cell Death Discov."},{"key":"496_CR4","unstructured":"Prevention, C. f. D. C. a. Acute Radiation Syndrome: Information for Clinicians,http:\/\/www.cdc.gov\/radiation-emergencies\/hcp\/clinical-guidance\/ars.html (2024)."},{"key":"496_CR5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1667\/RADE-23-00196.1","volume":"201","author":"TA Winters","year":"2024","unstructured":"Winters, T. A. et al. Gastrointestinal acute radiation syndrome: Mechanisms, models, markers, and medical countermeasures. Radiat. Res. 201, 628\u2013646 (2024).","journal-title":"Radiat. Res."},{"key":"496_CR6","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2023.226","volume":"18","author":"CI Rios","year":"2024","unstructured":"Rios, C. I. et al. Radiation and chemical program research for multi-utility and repurposed countermeasures: A US department of health and human services agencies perspective. Disaster Med Public Health Prep. 18, e35 (2024).","journal-title":"Disaster Med Public Health Prep."},{"key":"496_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1667\/RADE-24-00036.1","volume":"202","author":"JG Kiang","year":"2024","unstructured":"Kiang, J. G., Cannon, G. & Singh, V. K. An overview of radiation countermeasure development in radiation research from 1954 to 2024. Radiat. Res. 202, 420\u2013431 (2024).","journal-title":"Radiat. Res."},{"key":"496_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP\/TAZ: Hippo signaling and beyond. Physiol. Rev. 94, 1287\u20131312 (2014).","journal-title":"Physiol. Rev."},{"key":"496_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","volume":"13","author":"AW Hong","year":"2016","unstructured":"Hong, A. W., Meng, Z. & Guan, K. L. The Hippo pathway in intestinal regeneration and disease. Nat. Rev. Gastroenterol. Hepatol. 13, 324\u2013337 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"496_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-physiol-021014-071733","volume":"77","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Meng, Z., Plouffe, S. W. & Guan, K. L. Hippo pathway regulation of gastrointestinal tissues. Annu Rev. Physiol. 77, 201\u2013227 (2015).","journal-title":"Annu Rev. Physiol."},{"key":"496_CR11","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3390\/cells9081895","volume":"9","author":"S Fallah","year":"2020","unstructured":"Fallah, S. & Beaulieu, J. F. The Hippo pathway effector YAP1 regulates intestinal epithelial cell differentiation. Cells 9, 1895 (2020).","journal-title":"Cells"},{"key":"496_CR12","doi-asserted-by":"publisher","first-page":"E1312","DOI":"10.1073\/pnas.1110428108","volume":"108","author":"D Zhou","year":"2011","unstructured":"Zhou, D. et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc. Natl. Acad. Sci. USA. 108, E1312\u2013E1320 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1101\/gad.1978810","volume":"24","author":"J Cai","year":"2010","unstructured":"Cai, J. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383\u20132388 (2010).","journal-title":"Genes Dev."},{"key":"496_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811\u2013828 (2015).","journal-title":"Cell"},{"key":"496_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng, Z., Moroishi, T. & Guan, K. L. Mechanisms of Hippo pathway regulation. Genes Dev. 30, 1\u201317 (2016).","journal-title":"Genes Dev."},{"key":"496_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ceb.2012.12.006","volume":"25","author":"ER Barry","year":"2013","unstructured":"Barry, E. R. & Camargo, F. D. The Hippo superhighway: Signaling crossroads converging on the Hippo\/Yap pathway in stem cells and development. Curr. Opin. Cell Biol. 25, 247\u2013253 (2013).","journal-title":"Curr. Opin. Cell Biol."},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.15252\/embr.201438638","volume":"15","author":"JS Mo","year":"2014","unstructured":"Mo, J. S., Park, H. W. & Guan, K. L. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 15, 642\u2013656 (2014).","journal-title":"EMBO Rep."},{"key":"496_CR18","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/febs.13604","volume":"283","author":"DE Pefani","year":"2016","unstructured":"Pefani, D. E. & O\u2019Neill, E. Hippo pathway and protection of genome stability in response to DNA damage. FEBS J. 283, 1392\u20131403 (2016).","journal-title":"FEBS J."},{"key":"496_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/biomedicines8120560","volume":"8","author":"Y Seo","year":"2020","unstructured":"Seo, Y., Park, S. Y., Kim, H. S. & Nam, J. S. The Hippo-YAP signaling as guardian in the pool of intestinal stem cells. Biomedicines 8, 560 (2020).","journal-title":"Biomedicines"},{"key":"496_CR20","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054\u20132060 (2007).","journal-title":"Curr. Biol."},{"key":"496_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11693","volume":"493","author":"ER Barry","year":"2013","unstructured":"Barry, E. R. et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106\u2013110 (2013).","journal-title":"Nature"},{"key":"496_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105770","volume":"40","author":"O Guillermin","year":"2021","unstructured":"Guillermin, O. et al. Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration. EMBO J. 40, e105770 (2021).","journal-title":"EMBO J."},{"key":"496_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nature15382","volume":"526","author":"A Gregorieff","year":"2015","unstructured":"Gregorieff, A., Liu, Y., Inanlou, M. R., Khomchuk, Y. & Wrana, J. L. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer. Nature 526, 715\u2013718 (2015).","journal-title":"Nature"},{"key":"496_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.stem.2017.11.001","volume":"22","author":"S Yui","year":"2018","unstructured":"Yui, S. et al. YAP\/TAZ-dependent reprogramming of colonic epithelium links ECM remodeling to tissue regeneration. Cell Stem. Cell 22, 35\u201349.e37 (2018).","journal-title":"Cell Stem. Cell"},{"key":"496_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gad.262816.115","volume":"29","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T. et al. A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 29, 1271\u20131284 (2015).","journal-title":"Genes Dev."},{"key":"496_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.devcel.2021.12.012","volume":"57","author":"TE Ohara","year":"2022","unstructured":"Ohara, T. E., Colonna, M. & Stappenbeck, T. S. Adaptive differentiation promotes intestinal villus recovery. Dev. Cell 57, 166\u2013179.e166 (2022).","journal-title":"Dev. Cell"},{"key":"496_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","volume":"20","author":"IM Moya","year":"2019","unstructured":"Moya, I. M. & Halder, G. Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine. Nat. Rev. Mol. Cell Biol. 20, 211\u2013226 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"496_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41586-019-1154-y","volume":"569","author":"A Ayyaz","year":"2019","unstructured":"Ayyaz, A. et al. Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell. Nature 569, 121\u2013125 (2019).","journal-title":"Nature"},{"key":"496_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47124-8","volume":"15","author":"C Morral","year":"2024","unstructured":"Morral, C. et al. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury. Nat. Commun. 15, 3018 (2024).","journal-title":"Nat. Commun."},{"key":"496_CR30","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1038\/s41556-024-01550-4","volume":"26","author":"M Fink","year":"2024","unstructured":"Fink, M. et al. Chromatin remodelling in damaged intestinal crypts orchestrates redundant TGFbeta and Hippo signalling to drive regeneration. Nat. Cell Biol. 26, 2084\u20132098 (2024).","journal-title":"Nat. Cell Biol."},{"key":"496_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01626-w","volume":"16","author":"H Zhu","year":"2024","unstructured":"Zhu, H. et al. YAP represses intestinal inflammation through epigenetic silencing of JMJD3. Clin. Epigen. 16, 14 (2024).","journal-title":"Clin. Epigen."},{"key":"496_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113926","volume":"43","author":"Z Zhong","year":"2024","unstructured":"Zhong, Z., Jiao, Z. & Yu, F. X. The Hippo signaling pathway in development and regeneration. Cell Rep. 43, 113926 (2024).","journal-title":"Cell Rep."},{"key":"496_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro, A., Panciera, T. & Piccolo, S. YAP\/TAZ upstream signals and downstream responses. Nat. Cell Biol. 20, 888\u2013899 (2018).","journal-title":"Nat. Cell Biol."},{"key":"496_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206113119","volume":"119","author":"NR Kastan","year":"2022","unstructured":"Kastan, N. R. et al. Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs. Proc. Natl. Acad. Sci. USA 119, e2206113119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"496_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23395-3","volume":"12","author":"N Kastan","year":"2021","unstructured":"Kastan, N. et al. Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues. Nat. Commun. 12, 3100 (2021).","journal-title":"Nat. Commun."},{"key":"496_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1463465","volume":"15","author":"H Shen","year":"2024","unstructured":"Shen, H. et al. Lats-IN-1 protects cardiac function and promotes regeneration after myocardial infarction by targeting the hippo pathway. Front Pharm. 15, 1463465 (2024).","journal-title":"Front Pharm."},{"key":"496_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.stem.2024.03.003","volume":"31","author":"K Namoto","year":"2024","unstructured":"Namoto, K. et al. NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo. Cell Stem Cell 31, 554\u2013569 e517 (2024).","journal-title":"Cell Stem Cell"},{"key":"496_CR38","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1111\/bph.70137","volume":"182","author":"C Xiao","year":"2025","unstructured":"Xiao, C. et al. Pharmacological targeting of large tumor suppressor kinases (LATS) 1 and 2 augments tissue repair and regeneration. Br. J. Pharm. 182, 5536\u20135555 (2025).","journal-title":"Br. J. Pharm."},{"key":"496_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molcel.2018.08.038","volume":"72","author":"H Han","year":"2018","unstructured":"Han, H. et al. Regulation of the Hippo pathway by phosphatidic acid-mediated lipid-protein interaction. Mol. Cell 72, 328\u2013340 e328 (2018).","journal-title":"Mol. Cell"},{"key":"496_CR40","unstructured":"Morris, P. J., Duveau, D. Y., Thomas, C. J., Hoyt, S. B. & Ceribelli, M. Lats inhibitors and uses thereof. Patent, WO2023239727. 2023., (2023)."},{"key":"496_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28691-0","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma, S. et al. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER(+) breast cancer. Nat. Commun. 13, 1061 (2022).","journal-title":"Nat. Commun."},{"key":"496_CR42","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1074\/jbc.R114.635995","volume":"291","author":"NC Zachos","year":"2016","unstructured":"Zachos, N. C. et al. Human enteroids\/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem. 291, 3759\u20133766 (2016).","journal-title":"J. Biol. Chem."},{"key":"496_CR43","doi-asserted-by":"publisher","first-page":"E570","DOI":"10.1073\/pnas.1615422114","volume":"114","author":"K Saxena","year":"2017","unstructured":"Saxena, K. et al. A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc. Natl. Acad. Sci. USA. 114, E570\u2013E579 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"496_CR44","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aaf5211","volume":"353","author":"K Ettayebi","year":"2016","unstructured":"Ettayebi, K. et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 353, 1387\u20131393 (2016).","journal-title":"Science"},{"key":"496_CR45","doi-asserted-by":"publisher","first-page":"G734","DOI":"10.1152\/ajpgi.00186.2025","volume":"329","author":"V Poplaski","year":"2025","unstructured":"Poplaski, V. et al. Distinct molecular responses of human intestinal organoids to proton and photon radiation. Am. J. Physiol. Gastrointest. Liver Physiol. 329, G734\u2013G746 (2025).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"496_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jcmgh.2020.02.007","volume":"10","author":"PS Montenegro-Miranda","year":"2020","unstructured":"Montenegro-Miranda, P. S. et al. A novel organoid model of damage and repair identifies HNF4alpha as a critical regulator of intestinal epithelial regeneration. Cell Mol. Gastroenterol. Hepatol. 10, 209\u2013223 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"496_CR47","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"496_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02673-3","volume":"23","author":"R Wang","year":"2022","unstructured":"Wang, R. et al. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis. Genome Biol. 23, 106 (2022).","journal-title":"Genome Biol."},{"key":"496_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4494","volume":"5","author":"BJ Leibowitz","year":"2014","unstructured":"Leibowitz, B. J. et al. Ionizing irradiation induces acute haematopoietic syndrome and gastrointestinal syndrome independently in mice. Nat. Commun. 5, 3494 (2014).","journal-title":"Nat. Commun."},{"key":"496_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.1166202","volume":"327","author":"DG Kirsch","year":"2010","unstructured":"Kirsch, D. G. et al. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 327, 593\u2013596 (2010).","journal-title":"Science"},{"key":"496_CR51","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ijrobp.2018.07.192","volume":"102","author":"CL Lee","year":"2018","unstructured":"Lee, C. L. et al. Blocking cyclin-dependent kinase 4\/6 during single dose versus fractionated radiation therapy leads to opposite effects on acute gastrointestinal toxicity in mice. Int. J. Radiat. Oncol. Biol. Phys. 102, 1569\u20131576 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"496_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","volume":"137","author":"LG van der Flier","year":"2009","unstructured":"van der Flier, L. G., Haegebarth, A., Stange, D. E., van de Wetering, M. & Clevers, H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137, 15\u201317 (2009).","journal-title":"Gastroenterology"},{"key":"496_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.rpor.2011.05.001","volume":"16","author":"M Lopez","year":"2011","unstructured":"Lopez, M. & Martin, M. Medical management of the acute radiation syndrome. Rep. Pr. Oncol. Radiother. 16, 138\u2013146 (2011).","journal-title":"Rep. Pr. Oncol. Radiother."},{"key":"496_CR54","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah, L. J., El-Osta, A. & Karagiannis, T. C. gammaH2AX: A sensitive molecular marker of DNA damage and repair. Leukemia 24, 679\u2013686 (2010).","journal-title":"Leukemia"},{"key":"496_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi5253","volume":"7","author":"BJ Leibowitz","year":"2021","unstructured":"Leibowitz, B. J. et al. Interferon b drives intestinal regeneration after radiation. Sci. Adv. 7, eabi5253 (2021).","journal-title":"Sci. Adv."},{"key":"496_CR56","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/1541-7786.MCR-11-0052","volume":"9","author":"BJ Leibowitz","year":"2011","unstructured":"Leibowitz, B. J. et al. Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21. Mol. Cancer Res. 9, 616\u2013625 (2011).","journal-title":"Mol. Cancer Res."},{"key":"496_CR57","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1016\/j.cell.2024.05.001","volume":"187","author":"C Capdevila","year":"2024","unstructured":"Capdevila, C. et al. Time-resolved fate mapping identifies the intestinal upper crypt zone as an origin of Lgr5+ crypt base columnar cells. Cell 187, 3039\u20133055 e3014 (2024).","journal-title":"Cell"},{"key":"496_CR58","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.cell.2024.05.004","volume":"187","author":"E Malagola","year":"2024","unstructured":"Malagola, E. et al. Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury. Cell 187, 3056\u20133071 e3017 (2024).","journal-title":"Cell"},{"key":"496_CR59","doi-asserted-by":"publisher","unstructured":"Chua, J. et al. Lgr5+ stem cells maintain apex position in cell hierarchy of the intestinal epithelium during homeostasis and injury. bioRxiv. https:\/\/doi.org\/10.1101\/2025.11.09.687498 (2025).","DOI":"10.1101\/2025.11.09.687498"},{"key":"496_CR60","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.stem.2023.09.015","volume":"30","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. TGFB1 induces fetal reprogramming and enhances intestinal regeneration. Cell Stem. Cell 30, 1520\u20131537 e1528 (2023).","journal-title":"Cell Stem. Cell"},{"key":"496_CR61","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1038\/s41586-018-0370-1","volume":"562","author":"YM Nusse","year":"2018","unstructured":"Nusse, Y. M. et al. Publisher Correction: Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 562, E22 (2018).","journal-title":"Nature"},{"key":"496_CR62","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.stem.2020.07.003","volume":"27","author":"P Cheung","year":"2020","unstructured":"Cheung, P. et al. Regenerative reprogramming of the intestinal stem cell state via Hippo signaling suppresses metastatic colorectal cancer. Cell Stem. Cell 27, 590\u2013604.e599 (2020).","journal-title":"Cell Stem. Cell"},{"key":"496_CR63","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.stem.2020.03.002","volume":"26","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Lats1\/2 sustain intestinal stem cells and Wnt activation through TEAD-dependent and independent transcription. Cell Stem. Cell 26, 675\u2013692 e678 (2020).","journal-title":"Cell Stem. Cell"},{"key":"496_CR64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41556-021-00813-8","volume":"24","author":"H Han","year":"2022","unstructured":"Han, H. et al. The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1. Nat. Cell Biol. 24, 74\u201387 (2022).","journal-title":"Nat. Cell Biol."},{"key":"496_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70338","volume":"6","author":"R Bala","year":"2025","unstructured":"Bala, R. et al. Targeting the Hippo\/YAP pathway: A promising approach for cancer therapy and beyond. MedComm. 6, e70338 (2025).","journal-title":"MedComm"},{"key":"496_CR66","first-page":"612","volume":"24","author":"N Ghaboura","year":"2025","unstructured":"Ghaboura, N. Unraveling the Hippo pathway: YAP\/TAZ as central players in cancer metastasis and drug resistance. EXCLI J. 24, 612\u2013637 (2025).","journal-title":"EXCLI J."},{"key":"496_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05939-2","volume":"9","author":"MK Gill","year":"2018","unstructured":"Gill, M. K. et al. A feed forward loop enforces YAP\/TAZ signaling during tumorigenesis. Nat. Commun. 9, 3510 (2018).","journal-title":"Nat. Commun."},{"key":"496_CR68","first-page":"148","volume":"116","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Prognostic analysis of Yes-associated protein 1 in patients with colorectal cancer. A systematic review and meta-analysis. Rev. Esp. Enferm. Dig. 116, 148\u2013156 (2024).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"496_CR69","doi-asserted-by":"publisher","first-page":"e54211","DOI":"10.1371\/journal.pone.0054211","volume":"8","author":"HF Yuen","year":"2013","unstructured":"Yuen, H. F. et al. TAZ expression as a prognostic indicator in colorectal cancer. PLoS One 8, e54211 (2013).","journal-title":"PLoS One"},{"key":"496_CR70","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246\u2013257 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"496_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15178","volume":"8","author":"DW Morgens","year":"2017","unstructured":"Morgens, D. W. et al. Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nat. Commun. 8, 15178 (2017).","journal-title":"Nat. Commun."},{"key":"496_CR72","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1172\/JCI88410","volume":"126","author":"L Wei","year":"2016","unstructured":"Wei, L. et al. Inhibition of CDK4\/6 protects against radiation-induced intestinal injury in mice. J. Clin. Invest 126, 4076\u20134087 (2016).","journal-title":"J. Clin. Invest"},{"key":"496_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40993-5","volume":"14","author":"M Calafiore","year":"2023","unstructured":"Calafiore, M. et al. A tissue-intrinsic IL-33\/EGF circuit promotes epithelial regeneration after intestinal injury. Nat. Commun. 14, 5411 (2023).","journal-title":"Nat. Commun."},{"key":"496_CR74","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.3390\/ijms18102197","volume":"18","author":"K Subramanian Vignesh","year":"2017","unstructured":"Subramanian Vignesh, K. & Deepe, G. S. Jr. Metallothioneins: Emerging Modulators in Immunity and Infection. Int J. Mol. Sci. 18, 2197 (2017).","journal-title":"Int J. Mol. Sci."},{"key":"496_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.71279","volume":"8","author":"O Mohammed","year":"2025","unstructured":"Mohammed, O., Tufa, A. & Gizaw, S. T. Emerging roles of metallothioneins in human pathophysiology: A review. Health Sci. Rep. 8, e71279 (2025).","journal-title":"Health Sci. Rep."},{"key":"496_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103641","volume":"73","author":"SY Kwak","year":"2021","unstructured":"Kwak, S. Y. et al. Metallothionein 2 activation by pravastatin reinforces epithelial integrity and ameliorates radiation-induced enteropathy. EBioMedicine 73, 103641 (2021).","journal-title":"EBioMedicine"},{"key":"496_CR77","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1101\/gad.329763.119","volume":"33","author":"Y Xiao","year":"2019","unstructured":"Xiao, Y. et al. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis. Genes Dev. 33, 1491\u20131505 (2019).","journal-title":"Genes Dev."},{"key":"496_CR78","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(15)61167-9","volume":"386","author":"K Kamiya","year":"2015","unstructured":"Kamiya, K. et al. Long-term effects of radiation exposure on health. Lancet 386, 469\u2013478 (2015).","journal-title":"Lancet"},{"key":"496_CR79","doi-asserted-by":"publisher","first-page":"418","DOI":"10.33594\/000000721","volume":"58","author":"J Cheng","year":"2024","unstructured":"Cheng, J. et al. Anti-ceramide ScFv prophylaxis for first responders to a limited nuclear attack. Cell Physiol. Biochem. 58, 418\u2013430 (2024).","journal-title":"Cell Physiol. Biochem."},{"key":"496_CR80","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/milmed\/usae156","volume":"189","author":"VK Singh","year":"2024","unstructured":"Singh, V. K. et al. BIO 300: A prophylactic radiation countermeasure for acute radiation syndrome. Mil. Med. 189, 390\u2013398 (2024).","journal-title":"Mil. Med"},{"key":"496_CR81","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/milmed\/usaf325","volume":"190","author":"OO Fatanmi","year":"2025","unstructured":"Fatanmi, O. O. et al. Prophylactic administration of BIO 300, a radiation medical countermeasure, improves erythrocyte-associated parameters in the rhesus macaque model. Mil. Med. 190, 746\u2013754 (2025).","journal-title":"Mil. Med."},{"key":"496_CR82","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/genes13101756","volume":"13","author":"VP Kumar","year":"2022","unstructured":"Kumar, V. P. et al. Pre-administration of PLX-R18 cells protects mice from radiation-induced hematopoietic failure and lethality. Genes (Basel) 13, 1756 (2022).","journal-title":"Genes (Basel)"},{"key":"496_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42443-0","volume":"13","author":"GP Holmes-Hampton","year":"2023","unstructured":"Holmes-Hampton, G. P. et al. PEGylated thrombopoietin mimetic, JNJ\u201126366821 a novel prophylactic radiation countermeasure for acute radiation injury. Sci. Rep. 13, 15211 (2023).","journal-title":"Sci. Rep."},{"key":"496_CR84","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/ijms27042001","volume":"27","author":"L Wang","year":"2026","unstructured":"Wang, L. et al. Pre-exposure prophylaxis with vasculotide enhances survival and alleviates hematopoietic and gastrointestinal injury following lethal total body irradiation. Int. J. Mol. Sci. 27, 2001 (2026).","journal-title":"Int. J. Mol. Sci."},{"key":"496_CR85","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3390\/ijms26094055","volume":"26","author":"KT Liermann-Wooldrik","year":"2025","unstructured":"Liermann-Wooldrik, K. T. et al. Identification of potential prophylactic medical countermeasures against acute radiation syndrome (ARS). Int J. Mol. Sci. 26, 4055 (2025).","journal-title":"Int J. Mol. Sci."},{"key":"496_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96321-8","volume":"11","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Characterization of an in vitro 3D intestinal organoid model by using massive RNAseq-based transcriptome profiling. Sci. Rep. 11, 16668 (2021).","journal-title":"Sci. Rep."},{"key":"496_CR87","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.stemcr.2015.04.010","volume":"4","author":"SR Finkbeiner","year":"2015","unstructured":"Finkbeiner, S. R. et al. Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem. Cell Rep. 4, 1140\u20131155 (2015).","journal-title":"Stem. Cell Rep."},{"key":"496_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8387297","volume":"2017","author":"N Gjorevski","year":"2017","unstructured":"Gjorevski, N. & Ordonez-Moran, P. Intestinal stem cell niche insights gathered from both in vivo and novel in vitro models. Stem. Cells Int 2017, 8387297 (2017).","journal-title":"Stem. Cells Int"},{"key":"496_CR89","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","volume":"469","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415\u2013418 (2011).","journal-title":"Nature"},{"key":"496_CR90","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262\u2013265 (2009).","journal-title":"Nature"},{"key":"496_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.854740","volume":"10","author":"J Taelman","year":"2022","unstructured":"Taelman, J., Diaz, M. & Guiu, J. Human intestinal organoids: Promise and challenge. Front Cell Dev. Biol. 10, 854740 (2022).","journal-title":"Front Cell Dev. Biol."},{"key":"496_CR92","doi-asserted-by":"publisher","first-page":"17499","DOI":"10.1021\/acs.jmedchem.5c01027","volume":"68","author":"PJ Morris","year":"2025","unstructured":"Morris, P. J. et al. Discovery and optimization of LATS1 and LATS2 kinase inhibitors for use in regenerative medicine. J. Med. Chem. 68, 17499\u201317515 (2025).","journal-title":"J. Med. Chem."},{"key":"496_CR93","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nbt.2017","volume":"29","author":"T Anastassiadis","year":"2011","unstructured":"Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H. & Peterson, J. R. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1039\u20131045 (2011).","journal-title":"Nat. Biotechnol."},{"key":"496_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14620-6","volume":"11","author":"PC DeWeirdt","year":"2020","unstructured":"DeWeirdt, P. C. et al. Genetic screens in isogenic mammalian cell lines without single cell cloning. Nat. Commun. 11, 752 (2020).","journal-title":"Nat. Commun."},{"key":"496_CR95","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-3603-8_2","volume":"1422","author":"Y Maru","year":"2016","unstructured":"Maru, Y., Orihashi, K. & Hippo, Y. Lentivirus-based stable gene delivery into intestinal organoids. Methods Mol. Biol. 1422, 13\u201321 (2016).","journal-title":"Methods Mol. Biol."},{"key":"496_CR96","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ijrobp.2013.11.238","volume":"88","author":"CL Lee","year":"2014","unstructured":"Lee, C. L. et al. Assessing cardiac injury in mice with dual energy-MicroCT, 4D-MicroCT, and MicroSPECT imaging after partial heart irradiation. Int J. Radiat. Oncol. Biol. Phys. 88, 686\u2013693 (2014).","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"496_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"496_CR98","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/0300985820980049","volume":"58","author":"TA Donovan","year":"2021","unstructured":"Donovan, T. A. et al. Mitotic figures-normal, atypical, and imposters: A guide to identification. Vet. Pathol. 58, 243\u2013257 (2021).","journal-title":"Vet. Pathol."},{"key":"496_CR99","first-page":"275","volume":"18","author":"M Stephens","year":"2017","unstructured":"Stephens, M. False discovery rates: A new deal. Biostatistics 18, 275\u2013294 (2017).","journal-title":"Biostatistics"},{"key":"496_CR100","doi-asserted-by":"publisher","unstructured":"Korotkevich, G., Sukhov, V. & Sergushichev, A. Fast gene set enrichment analysis. bioRxiv. https:\/\/doi.org\/10.1101\/060012 (2019).","DOI":"10.1101\/060012"},{"key":"496_CR101","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1038\/onc.2016.502","volume":"36","author":"M Fischer","year":"2017","unstructured":"Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943\u20133956 (2017).","journal-title":"Oncogene"},{"key":"496_CR102","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"496_CR103","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1101\/gad.1406006","volume":"20","author":"BC Nguyen","year":"2006","unstructured":"Nguyen, B. C. et al. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20, 1028\u20131042 (2006).","journal-title":"Genes Dev."},{"key":"496_CR104","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMoa044238","volume":"352","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi, S. et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 352, 786\u2013792 (2005).","journal-title":"N. Engl. J. Med"},{"key":"496_CR105","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1128\/MCB.01789-06","volume":"27","author":"O Delpuech","year":"2007","unstructured":"Delpuech, O. et al. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression. Mol. Cell Biol. 27, 4917\u20134930 (2007).","journal-title":"Mol. Cell Biol."},{"key":"496_CR106","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1152\/physiolgenomics.00303.2004","volume":"21","author":"G Karlsson","year":"2005","unstructured":"Karlsson, G. et al. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol. Genomics 21, 396\u2013403 (2005).","journal-title":"Physiol. Genomics"},{"key":"496_CR107","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature05674","volume":"446","author":"OJ Sansom","year":"2007","unstructured":"Sansom, O. J. et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676\u2013679 (2007).","journal-title":"Nature"},{"key":"496_CR108","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.celrep.2013.09.005","volume":"5","author":"RC Mustata","year":"2013","unstructured":"Mustata, R. C. et al. Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium. Cell Rep. 5, 421\u2013432 (2013).","journal-title":"Cell Rep."},{"key":"496_CR109","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"496_CR110","unstructured":"Dolgalev, I. in CRAN (2026)."}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00496-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:04:00Z","timestamp":1794359040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00496-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1038\/s41536-026-00496-5","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interests: P.J.M., D.Y.D., M.C., C.J.T., and S.B.H. are inventors on the patent \u201cSynthesis of pyrrolopyridine dual Lats\/AKT inhibitors treating wounds, cancers, and heavy metal poisoning\u201d WO2023239727. Their rights have been assigned to the US Government, but they may receive royalties on the patent. L.M.D. and C-L.L. are inventors on the provisional patent application, \u201cMethods of protecting against gastrointestinal acute radiation syndrome by inhibiting LATS1\/2\", filed on April 1, 2026, by Duke University. The remaining authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"50"}}